Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Comparison of baricitinib, upadacitinib, and tofacitinib mediated regulation of cytokine signaling in human leukocyte subpopulations.

McInnes IB, Byers NL, Higgs RE, Lee J, Macias WL, Na S, Ortmann RA, Rocha G, Rooney TP, Wehrman T, Zhang X, Zuckerman SH, Taylor PC.

Arthritis Res Ther. 2019 Aug 2;21(1):183. doi: 10.1186/s13075-019-1964-1.

2.

Clinical outcomes in patients switched from adalimumab to baricitinib due to non-response and/or study design: phase III data in patients with rheumatoid arthritis.

Tanaka Y, Fautrel B, Keystone EC, Ortmann RA, Xie L, Zhu B, Issa M, Patel H, Gaich CL, de Bono S, Rooney TP, Taylor PC.

Ann Rheum Dis. 2019 Jul;78(7):890-898. doi: 10.1136/annrheumdis-2018-214529. Epub 2019 Apr 30.

3.

Safety profile of baricitinib in Japanese patients with active rheumatoid arthritis with over 1.6 years median time in treatment: An integrated analysis of Phases 2 and 3 trials.

Harigai M, Takeuchi T, Smolen JS, Winthrop KL, Nishikawa A, Rooney TP, Saifan CG, Issa M, Isaka Y, Akashi N, Ishii T, Tanaka Y.

Mod Rheumatol. 2020 Jan;30(1):36-43. doi: 10.1080/14397595.2019.1583711. Epub 2019 Mar 21.

PMID:
30784354
4.

Cardiovascular Safety During Treatment With Baricitinib in Rheumatoid Arthritis.

Taylor PC, Weinblatt ME, Burmester GR, Rooney TP, Witt S, Walls CD, Issa M, Salinas CA, Saifan C, Zhang X, Cardoso A, González-Gay MA, Takeuchi T.

Arthritis Rheumatol. 2019 Jul;71(7):1042-1055. doi: 10.1002/art.40841. Epub 2019 May 25.

5.

Dose reduction of baricitinib in patients with rheumatoid arthritis achieving sustained disease control: results of a prospective study.

Takeuchi T, Genovese MC, Haraoui B, Li Z, Xie L, Klar R, Pinto-Correia A, Otawa S, Lopez-Romero P, de la Torre I, Macias W, Rooney TP, Smolen JS.

Ann Rheum Dis. 2019 Feb;78(2):171-178. doi: 10.1136/annrheumdis-2018-213271. Epub 2018 Sep 7.

6.

Characterization and Changes of Lymphocyte Subsets in Baricitinib-Treated Patients With Rheumatoid Arthritis: An Integrated Analysis.

Tanaka Y, McInnes IB, Taylor PC, Byers NL, Chen L, de Bono S, Issa M, Macias WL, Rogai V, Rooney TP, Schlichting DE, Zuckerman SH, Emery P.

Arthritis Rheumatol. 2018 Dec;70(12):1923-1932. doi: 10.1002/art.40680. Epub 2018 Oct 22.

7.

Effects of baricitinib on radiographic progression of structural joint damage at 1 year in patients with rheumatoid arthritis and an inadequate response to conventional synthetic disease-modifying antirheumatic drugs.

van der Heijde D, Dougados M, Chen YC, Greenwald M, Drescher E, Klar R, Xie L, de la Torre I, Rooney TP, Witt SL, Schlichting DE, de Bono S, Emery P.

RMD Open. 2018 May 8;4(1):e000662. doi: 10.1136/rmdopen-2018-000662. eCollection 2018.

8.

Lipid profile and effect of statin treatment in pooled phase II and phase III baricitinib studies.

Taylor PC, Kremer JM, Emery P, Zuckerman SH, Ruotolo G, Zhong J, Chen L, Witt S, Saifan C, Kurzawa M, Otvos JD, Connelly MA, Macias WL, Schlichting DE, Rooney TP, de Bono S, McInnes IB.

Ann Rheum Dis. 2018 Jul;77(7):988-995. doi: 10.1136/annrheumdis-2017-212461. Epub 2018 Feb 20. Review.

9.

Response to baricitinib based on prior biologic use in patients with refractory rheumatoid arthritis.

Genovese MC, Kremer JM, Kartman CE, Schlichting DE, Xie L, Carmack T, Pantojas C, Sanchez Burson J, Tony HP, Macias WL, Rooney TP, Smolen JS.

Rheumatology (Oxford). 2018 May 1;57(5):900-908. doi: 10.1093/rheumatology/kex489.

10.

Efficacy and safety of baricitinib in Japanese patients with rheumatoid arthritis: Subgroup analyses of four multinational phase 3 randomized trials.

Tanaka Y, Atsumi T, Amano K, Harigai M, Ishii T, Kawaguchi O, Rooney TP, Akashi N, Takeuchi T.

Mod Rheumatol. 2018 Jul;28(4):583-591. doi: 10.1080/14397595.2017.1392057. Epub 2017 Nov 14.

PMID:
29134891
11.

Safety and Efficacy of Baricitinib Through 128 Weeks in an Open-label, Longterm Extension Study in Patients with Rheumatoid Arthritis.

Keystone EC, Genovese MC, Schlichting DE, de la Torre I, Beattie SD, Rooney TP, Taylor PC.

J Rheumatol. 2018 Jan;45(1):14-21. doi: 10.3899/jrheum.161161. Epub 2017 Aug 15.

12.

Deer herbivory reduces web-building spider abundance by simplifying forest vegetation structure.

Roberson EJ, Chips MJ, Carson WP, Rooney TP.

PeerJ. 2016 Sep 29;4:e2538. doi: 10.7717/peerj.2538. eCollection 2016.

13.

Isoxazole-Derived Amino Acids are Bromodomain-Binding Acetyl-Lysine Mimics: Incorporation into Histone H4 Peptides and Histone H3.

Sekirnik Née Measures AR, Hewings DS, Theodoulou NH, Jursins L, Lewendon KR, Jennings LE, Rooney TP, Heightman TD, Conway SJ.

Angew Chem Int Ed Engl. 2016 Jul 11;55(29):8353-7. doi: 10.1002/anie.201602908. Epub 2016 Jun 6.

14.

Baricitinib in Patients with Refractory Rheumatoid Arthritis.

Genovese MC, Kremer J, Zamani O, Ludivico C, Krogulec M, Xie L, Beattie SD, Koch AE, Cardillo TE, Rooney TP, Macias WL, de Bono S, Schlichting DE, Smolen JS.

N Engl J Med. 2016 Mar 31;374(13):1243-52. doi: 10.1056/NEJMoa1507247.

15.

Correction to Small Molecule Inhibitors of Bromodomain-Acetyl-lysine Interactions.

Brand M, Measures AR, Wilson BG, Cortopassi WA, Alexander R, Höss M, Hewings DS, Rooney TP, Paton RS, Conway SJ.

ACS Chem Biol. 2016 Apr 15;11(4):1148. doi: 10.1021/acschembio.5b01065. Epub 2016 Jan 12. No abstract available.

PMID:
26756254
16.

Small molecule inhibitors of bromodomain-acetyl-lysine interactions.

Brand M, Measures AR, Wilson BG, Cortopassi WA, Alexander R, Höss M, Hewings DS, Rooney TP, Paton RS, Conway SJ.

ACS Chem Biol. 2015 Jan 16;10(1):22-39. doi: 10.1021/cb500996u. Review. Erratum in: ACS Chem Biol. 2016 Apr 15;11(4):1148. Measures, Angelina M [corrected to Measures, Angelina R].

PMID:
25549280
17.

Safety and efficacy of baricitinib at 24 weeks in patients with rheumatoid arthritis who have had an inadequate response to methotrexate.

Keystone EC, Taylor PC, Drescher E, Schlichting DE, Beattie SD, Berclaz PY, Lee CH, Fidelus-Gort RK, Luchi ME, Rooney TP, Macias WL, Genovese MC.

Ann Rheum Dis. 2015 Feb;74(2):333-40. doi: 10.1136/annrheumdis-2014-206478. Epub 2014 Nov 27.

18.

Discovery and optimization of small-molecule ligands for the CBP/p300 bromodomains.

Hay DA, Fedorov O, Martin S, Singleton DC, Tallant C, Wells C, Picaud S, Philpott M, Monteiro OP, Rogers CM, Conway SJ, Rooney TP, Tumber A, Yapp C, Filippakopoulos P, Bunnage ME, Müller S, Knapp S, Schofield CJ, Brennan PE.

J Am Chem Soc. 2014 Jul 2;136(26):9308-19. doi: 10.1021/ja412434f. Epub 2014 Jun 19.

19.

White-tailed deer are a biotic filter during community assembly, reducing species and phylogenetic diversity.

Begley-Miller DR, Hipp AL, Brown BH, Hahn M, Rooney TP.

AoB Plants. 2014 Jun 9;6. pii: plu030. doi: 10.1093/aobpla/plu030.

20.

A series of potent CREBBP bromodomain ligands reveals an induced-fit pocket stabilized by a cation-π interaction.

Rooney TP, Filippakopoulos P, Fedorov O, Picaud S, Cortopassi WA, Hay DA, Martin S, Tumber A, Rogers CM, Philpott M, Wang M, Thompson AL, Heightman TD, Pryde DC, Cook A, Paton RS, Müller S, Knapp S, Brennan PE, Conway SJ.

Angew Chem Int Ed Engl. 2014 Jun 10;53(24):6126-30. doi: 10.1002/anie.201402750. Epub 2014 May 12.

21.

Progress in the development and application of small molecule inhibitors of bromodomain-acetyl-lysine interactions.

Hewings DS, Rooney TP, Jennings LE, Hay DA, Schofield CJ, Brennan PE, Knapp S, Conway SJ.

J Med Chem. 2012 Nov 26;55(22):9393-413. doi: 10.1021/jm300915b. Epub 2012 Sep 27. Review.

PMID:
22924434
22.

Community-associated methicillin-resistant Staphylococcus aureus survival on artificial turf substrates.

Waninger KN, Rooney TP, Miller JE, Berberian J, Fujimoto A, Buttaro BA.

Med Sci Sports Exerc. 2011 May;43(5):779-84. doi: 10.1249/MSS.0b013e3182006819.

PMID:
20962684
23.

Paying the extinction debt in southern Wisconsin forest understories.

Rogers DA, Rooney TP, Hawbaker TJ, Radeloff VC, Waller DM.

Conserv Biol. 2009 Dec;23(6):1497-506. doi: 10.1111/j.1523-1739.2009.01256.x. Epub 2009 Jun 8.

PMID:
19508676
24.

Shifts in southern Wisconsin forest canopy and understory richness, composition, and heterogeneity.

Rogers DA, Rooney TP, Olson D, Waller DM.

Ecology. 2008 Sep;89(9):2482-92.

PMID:
18831170
25.

Nature is changing in more ways than one.

Waller DM, Rooney TP.

Trends Ecol Evol. 2004 Jan;19(1):6-7; author reply 7. No abstract available.

PMID:
16701217
26.

Effect of estradiol on the temporal pattern of exercise-induced tissue glycogen depletion in male rats.

Rooney TP, Kendrick ZV, Carlson J, Ellis GS, Matakevich B, Lorusso SM, McCall JA.

J Appl Physiol (1985). 1993 Oct;75(4):1502-6.

PMID:
8282595
27.

Rapid condylar degeneration after glenoid fossa prosthesis insertion: report of three cases.

Rooney TP, Haug RH, Toor AH, Indresano AT.

J Oral Maxillofac Surg. 1988 Mar;46(3):240-6.

PMID:
3280762
28.

Effective one-visit therapy for the acute periapical abscess.

Southard DW, Rooney TP.

J Endod. 1984 Dec;10(12):580-3. No abstract available.

PMID:
6596388
29.

Dental caries prevalence in patients with Crohn's disease.

Rooney TP.

Oral Surg Oral Med Oral Pathol. 1984 Jun;57(6):623-4.

PMID:
6588344
30.

General dentistry during continuous anticoagulation therapy.

Rooney TP.

Oral Surg Oral Med Oral Pathol. 1983 Sep;56(3):252-5.

PMID:
6226911
31.

Outpatient management of mentally handicapped patients undergoing dental procedures.

Indresano AT, Rooney TP.

J Am Dent Assoc. 1981 Mar;102(3):328-30.

PMID:
6450793
32.

Deformation twins in hornblende.

Rooney TP, Riecker RE, Ross M.

Science. 1970 Jul 10;169(3941):173-5.

PMID:
17828963
33.

Spectral emittance and reflectance of powders.

Aronson JR, Emslie AG, Rooney TP, Coleman I, Horlick G.

Appl Opt. 1969 Aug 1;8(8):1639-43. doi: 10.1364/AO.8.001639.

PMID:
20072490
34.

High-pressure reactions and shear strength of serpentinized dunite.

Sclar CB, Carrison LC, Rooney TP, Riecker RE.

Science. 1966 Sep 9;153(3741):1285-7.

PMID:
17754251
35.

Weakening of dunite by serpentine dehydration.

Riecker RE, Rooney TP.

Science. 1966 Apr 8;152(3719):196-8.

PMID:
17741630
36.

Chinoptilolite: A New Occurrence in North Carolina Phosphorite.

Rooney TP, Kerr PF.

Science. 1964 Jun 19;144(3625):1453.

PMID:
17777112

Supplemental Content

Loading ...
Support Center